A new clinical trial from drugmaker Eli Lilly shows that Zepbound and Mounjaro reduced obstructive sleep apnea symptoms. Tirzepatide, the main ingredient in these medications, reduced symptom severity by nearly two-thirds. Around 20% of participants taking tirzepatide experienced weight loss.
As the popularity of semaglutide weight-loss medications continues to grow, so does the rate of potentially dangerous overdoses. Experts share warning signs and prevention tips.
As the popularity of semaglutide weight loss medications continues to grow, so does the rate of potentially dangerous overdoses. Experts share warning signs and prevention tips.
The Food and Drug Administration is investigating reports of side effects from GLP-1 drugs like Ozempic and Wegovy, including suicidal ideation and hair loss. A large new study found no link between semaglutide, the active ingredient in some GLP-1 drugs, and suicidal ideation.